SPDR Advertisement SureTrader Stock Hero Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 65
Posts 5,045
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Compugen to Present at Two Oncology Conferences in March "Business Wire" - 3/2/2015 7:09:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/27/2015 4:08:31 PM
Compugen Expands and Strengthens Business Development Team "Business Wire" - 2/23/2015 7:04:00 AM
Compugen Ltd. Reports Fourth Quarter and Calendar 2014 Results "Business Wire" - 2/10/2015 7:10:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/10/2015 7:01:33 AM
Compugen Presents New Results Supporting CGEN-15049 as Potential Cancer Immunotherapy Target "Business Wire" - 2/9/2015 7:14:00 AM
Compugen Fourth Quarter and Year-End 2014 Conference Call Scheduled for Tuesday, February 10, 2015 at 10:00 AM EST "Business Wire" - 2/3/2015 7:09:00 AM
Compugen to Present Cancer Immunotherapy Targets at Two Tumor Immunology Conferences This Month "Business Wire" - 2/2/2015 7:39:00 AM
Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets "Business Wire" - 1/5/2015 7:14:00 AM
Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University "Business Wire" - 12/18/2014 7:02:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/18/2014 7:01:03 AM
Compugen to Present at Oppenheimer 25th Annual Healthcare Conference "Business Wire" - 12/3/2014 7:01:00 AM
Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of Cancer-Related Immune Checkpoints "Business Wire" - 12/2/2014 7:07:00 AM
Compugen to Present at Jefferies 2014 Global Healthcare Conference in London "Business Wire" - 11/12/2014 7:01:00 AM
Compugen Ltd. Reports Third Quarter 2014 Financial Results "Business Wire" - 10/29/2014 7:13:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/29/2014 7:07:45 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/28/2014 7:02:43 AM
Compugen Discloses Successful Validation Results for Novel B7/CD28–like Cancer Immunotherapy Target Candidate "Business Wire" - 10/27/2014 7:01:00 AM
Compugen Third Quarter 2014 Conference Call Scheduled for Wednesday, October 29, 2014 at 10:00 AM ET "Business Wire" - 10/22/2014 7:11:00 AM
Compugen Achieves Second Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer "Business Wire" - 10/14/2014 2:02:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/14/2014 1:49:35 PM
Compugen Immune Checkpoint Results Being Presented at Three Scientific Conferences "Business Wire" - 10/6/2014 7:08:00 AM
Compugen Discloses New Results for Novel Target Candidate for Cancer Immunotherapy "Business Wire" - 10/1/2014 7:01:00 AM
Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction "Business Wire" - 9/29/2014 7:04:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 9/5/2014 6:00:20 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist